Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of eye disorders
3.2.1.2 Technological advancements in ophthalmic drug delivery systems
3.2.1.3 Increasing geriatric population coupled with disease
3.2.1.4 Increasing awareness and diagnosis
3.2.2 Industry pitfalls & challenges
3.2.2.1 Non-compliance and poor adherence
3.2.2.2 Associated side effects and tolerance issues
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Eye Dropper, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Unidose eye dropper
5.3 Preserved multi-dose eye dropper
5.4 Preservative-free multi-dose eye dropper
Chapter 6 Market Estimates and Forecast, By Mode, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Prescription drugs
6.3 Over the counter (OTC) drugs
Chapter 7 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Glaucoma
7.3 Allergies
7.4 Conjunctivitis
7.5 Dry eye
7.6 Other indications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ophthalmic clinics
8.4 Homecare settings
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie Inc.
10.2 Alcon plc
10.3 AptarGroup, Inc.
10.4 Bausch & Lomb Incorporated
10.5 Novartis AG
10.6 PanOptica, Inc.
10.7 Pfizer Inc
10.8 Sager Pharma Kft
10.9 Silgan Dispensing Systems LLC
10.10 Similasan Corp
